•70 Candidiasis AEs
–MVC QD 41
AEs in 26 (6.2%) subjects
–MVC BID 18
AEs in 17 (4.0%) subjects
–Placebo 11
AEs in 11 (5.3%) subjects
–
•19 Category C Candidiasis AEs
–MVC QD 14
AEs in 12 (2.9%) subjects
–MVC BID 3
AEs in 3 (0.7%) subjects
–Placebo 2
AEs in 2 (1.0%) subjects